Trial Search Results

Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial

The purpose of this 12-month double blind, placebo controlled randomized trial is to evaluate the effects of daily treatments with low magnitude mechanical stimuli on bone in 160 children with Crohn disease.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Children's Hospital of Philadelphia

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):


  • Device: Low magnitude mechanical stimulus
  • Device: Placebo (inactive) low magnitude mechanical stimulus




Inclusion Criteria:

   - Age 8-21 years

   - Diagnosis of Crohn disease > 6 months

   - Tibia vBMD z-score < 25th%tile for age and sex

Exclusion Criteria:

   - Pregnancy

   - Weight > 250 lb

   - Medical illness (unrelated to Crohn)

   - Cognitive/developmental disorder

   - Do not speak English

   - > 1 primary residence

   - Unwilling to commit to 2 year study

   - Sibling or cousin enrolled in trial

Ages Eligible for Study

8 Years - 21 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting